Contraception and Family Planning Practice Questions

Q: What is the recommended lifespan of a Copper T 380A intrauterine device?

10 years. **Explanation:** The **Copper T 380A (CuT 380A)** is a highly effective, long-acting reversible contraceptive (LARC). The "380" refers to the surface area of copper wire (380 $mm^2$) wrapped around the vertical stem and the copper sleeves on the horizontal arms. This high copper content increases its efficacy and longevity. **Why Option D is Correct:** The FDA and the Government of India (under the National Family Planning Program) recommend a lifespan of **10 years** for the CuT 380A. The primary mechanism of action is the release of copper ions, which are spermicidal, inhibit sperm motility, and cause a sterile inflammatory response in the endometrium, preventing implantation. **Why Other Options are Incorrect:** * **Options A & C (3-4 years):** These are too short for modern copper IUDs. Older models like the Lippes Loop or CuT 200 had shorter durations, but they are no longer the standard of care. * **Option B (5 years):** This is the lifespan of the **CuT 375 (Multiload)** and the **Mirena (LNG-IUD)**. While Mirena is now often used for up to 8 years in some clinical guidelines, 5 years remains the standard duration for CuT 375. **High-Yield Clinical Pearls for NEET-PG:** * **Ideal Insertion Time:** Within 10 days of the onset of menstruation (to ensure the patient is not pregnant and the cervix is slightly dilated). * **Post-Placental Insertion:** Can be inserted within 48 hours of delivery (PPIUCD). * **Emergency Contraception:** CuT 380A is the **most effective** method of emergency contraception if inserted within 5 days (120 hours) of unprotected intercourse. * **Common Side Effects:** The most common side effect is **menorrhagia** (increased menstrual bleeding), followed by pelvic pain.

Q: A 27-year-old P2L2 presents to the OPD for contraceptive advice. She delivered a male child 3 weeks ago and is presently lactating. She has no contraindications to hormone use. What contraceptive method can be given?

Minipill (Progestin-only pill). **Explanation:** The primary concern in postpartum contraception for a lactating woman is the effect of hormones on the **quantity and quality of breast milk**, as well as the risk of **venous thromboembolism (VTE)**. **1. Why Option B (Minipill) is Correct:** Progestin-only pills (POPs) are the preferred hormonal method for breastfeeding women. According to the WHO Medical Eligibility Criteria (MEC), POPs can be started as early as **immediately postpartum** (Category 2 if 6 weeks). They do not suppress lactation or affect the nutritional quality of milk, making them safe for both the mother and the infant. **2. Why the other options are incorrect:** * **Option D (Combined OCPs):** These are **contraindicated** in the first 3–6 weeks postpartum. Estrogen suppresses prolactin, leading to decreased milk production. Furthermore, the postpartum period is a hypercoagulable state; estrogen increases the risk of VTE. (MEC Category 4 if <3 weeks; Category 3 if 3–6 weeks). * **Option A & C (DMPA and Implants):** While these are progestin-only methods, the WHO MEC traditionally suggests waiting until **6 weeks** postpartum for DMPA in breastfeeding women (Category 2) to avoid theoretical concerns regarding high-dose steroid exposure to the neonate during early development. The Minipill is considered a more immediate option at 3 weeks. **Clinical Pearls for NEET-PG:** * **Lactational Amenorrhea Method (LAM):** Effective only if the mother is exclusively breastfeeding, is amenorrheic, and the baby is <6 months old. * **IUCD (Cu-T):** Can be inserted within 48 hours (Postpartum IUCD) or after 6 weeks (Interval IUCD). It should *not* be inserted between 48 hours and 6 weeks due to high perforation/expulsion risks. * **Ideal Postpartum Sterilization:** Usually performed within 24–48 hours or after 6 weeks.

Q: Which of the following statements is TRUE regarding spermicides found in vaginal foams, creams, and suppositories?

The active agent in these spermicides is nonoxynol-9.. **Explanation:** **1. Why Option A is Correct:** The primary active ingredient in most commercially available spermicides (foams, creams, gels, and suppositories) is **Nonoxynol-9**. It is a non-ionic surfactant that works by disrupting the sperm cell membrane (lipids), leading to loss of motility and eventual cell death. This prevents the sperm from reaching and fertilizing the ovum. **2. Why the Other Options are Incorrect:** * **Option B:** **Levonorgestrel** is a synthetic progestogen used in hormonal contraceptives (like the LNG-IUS, POPs, or emergency contraceptive pills), not in chemical spermicides. * **Option C:** Effectiveness is generally **lower in younger users**. This is because younger populations are typically more fertile and have a higher coital frequency, leading to a higher failure rate compared to older users. * **Option D:** Spermicides used alone have a high failure rate (approximately 18–28% with typical use). Their effectiveness is **lower than the diaphragm** and other barrier methods. For optimal efficacy, spermicides are recommended to be used in conjunction with a diaphragm or condom. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Nonoxynol-9 acts as a detergent that destroys the sperm's plasma membrane. * **HIV Risk:** Frequent use of Nonoxynol-9 can cause vaginal and cervical irritation/epithelial disruption, which may actually **increase the risk of HIV transmission** and other STIs. * **Application:** Spermicides must be applied high in the vagina near the cervix, usually 10–30 minutes before intercourse, and their effect lasts for about one hour. * **Pearl:** Spermicides do not protect against STIs; in fact, the WHO does not recommend Nonoxynol-9 for women at high risk of HIV.

Q: What is the primary mechanism of action of oral contraceptives containing ethinyl estradiol and a progestin?

Inhibition of ovulation. Combined Oral Contraceptive Pills (COCPs) containing both ethinyl estradiol and a progestin act via multiple mechanisms, but their **primary** mechanism of action is the **inhibition of ovulation**. ### Why Option A is Correct The combination of hormones exerts negative feedback on the hypothalamic-pituitary-ovarian axis: * **Estrogen** suppresses the release of **FSH** (Follicle Stimulating Hormone), which prevents the recruitment and maturation of a dominant follicle. * **Progestin** suppresses the release of **LH** (Luteinizing Hormone), thereby preventing the LH surge required for ovulation. Without follicle maturation or an LH surge, ovulation cannot occur. ### Why Other Options are Incorrect * **Option B (Inhibition of implantation):** While COCPs cause endometrial atrophy (making it less receptive), this is a secondary/backup effect, not the primary mechanism. * **Option C (Thickening of cervical mucus):** This is the **primary** mechanism for **Progestogen-Only Pills (POPs)** and the Minipill. In COCPs, this is a secondary mechanism that prevents sperm penetration. ### High-Yield NEET-PG Pearls * **Most potent component for ovulation inhibition:** Progestin (it is responsible for the mid-cycle LH suppression). * **Pearl on Failure Rate:** The "Perfect Use" failure rate of COCPs is **0.3%**, while "Typical Use" is approximately **9%**. * **Non-contraceptive benefits:** COCPs reduce the risk of **Ovarian and Endometrial cancers** (protective effect). * **Contraindication:** Avoid in women >35 years who smoke (increased risk of venous thromboembolism).

Q: What is the most common side effect of an Intrauterine Contraceptive Device (IUCD) that necessitates its removal?

Pain. The correct answer is **Pain (Option B)**. ### **Explanation** While **bleeding** (menorrhagia or intermenstrual spotting) is statistically the **most common side effect** overall associated with IUCD use, **pain** (dysmenorrhea or pelvic cramping) is the **most common reason for medical removal** of the device. The underlying medical concept is based on patient tolerance: most women can manage or be treated for increased menstrual flow with NSAIDs or antifibrinolytics. However, persistent or severe pelvic pain is often perceived as intolerable or indicative of complications (like displacement or PID), leading both the patient and the clinician to opt for removal. ### **Analysis of Incorrect Options** * **A. Bleeding:** This is the most frequent side effect, but it is second to pain as a reason for discontinuation/removal. * **C. Pelvic Infection:** While IUCDs (specifically the insertion process) slightly increase the risk of Pelvic Inflammatory Disease (PID) in the first 20 days, it is a relatively rare complication and not the primary reason for removal. * **D. Ectopic Pregnancy:** An IUCD significantly reduces the *absolute* risk of ectopic pregnancy by preventing pregnancy overall. However, if a woman *does* conceive with an IUCD in situ, the *relative* risk that the pregnancy is ectopic is higher. ### **High-Yield Clinical Pearls for NEET-PG** * **Most common side effect:** Bleeding. * **Most common cause for removal:** Pain. * **Most common complication:** Expulsion (most likely to occur in the first 3 months, during menstruation). * **Ideal time for insertion:** Within 10 days of the onset of menstruation (to ensure the patient is not pregnant and the cervix is slightly dilated). * **Mechanism of Action (Cu-T):** Primarily a sterile inflammatory response in the endometrium which is spermicidal.

Q: Centchroman is:

A nonsteroidal oral contraceptive. **Explanation:** **Centchroman (Ormeloxifene)** is a unique **non-steroidal, non-hormonal oral contraceptive** developed by the Central Drug Research Institute (CDRI), Lucknow, India. It belongs to the class of **Selective Estrogen Receptor Modulators (SERMs)**. It works by antagonizing estrogen receptors in the uterus, thereby altering the endometrial receptivity and preventing the implantation of the blastocyst. Since it does not suppress ovulation, the normal hormonal milieu of the body remains undisturbed. **Analysis of Options:** * **Option A & B:** While SERMs are sometimes explored for estrogen-dependent conditions, Centchroman is primarily indicated and marketed as a contraceptive and for the treatment of Dysfunctional Uterine Bleeding (DUB). It is not the standard "new drug" for fibroids (where Ulipristal or GnRH analogues are used) or endometriosis (where Dienogest or GnRH analogues are preferred). * **Option C:** Centchroman is an **oral pill**, not an injectable. Common injectables include DMPA (Antara program) and NET-EN. * **Option D:** This is correct as Centchroman is the only non-steroidal oral contraceptive pill available, famously known by the brand names **Saheli** or **Chhaya** (under the National Family Planning Program). **High-Yield Clinical Pearls for NEET-PG:** * **Dosage Schedule:** 30 mg **twice weekly** for the first 3 months, followed by **once weekly** thereafter. * **Major Side Effect:** The most common side effect is a **prolonged menstrual cycle** (delayed periods), which occurs in about 8% of users. * **Safety Profile:** It has no steroid-related side effects like weight gain, nausea, or mood swings, and it is safe for use during **lactation**. * **Other Uses:** It is highly effective in treating **Mastalgia** and **Dysfunctional Uterine Bleeding (DUB)**.

Q: Which of the following is NOT an absolute contraindication for oral contraceptive pills?

Smoking. In the context of Combined Oral Contraceptive Pills (COCPs), it is crucial to distinguish between **Absolute Contraindications (WHO Category 4)** and **Relative Contraindications (WHO Category 3)**. ### Why Smoking is the Correct Answer Smoking is **not** an absolute contraindication for all women. According to the WHO Medical Eligibility Criteria (MEC), smoking is only an absolute contraindication (Category 4) if the woman is **$\geq$ 35 years old and smokes $\geq$ 15 cigarettes per day**. For women under 35 or those who smoke fewer than 15 cigarettes, it is considered a relative contraindication. Therefore, "Smoking" as a standalone option is not an absolute contraindication. ### Why Other Options are Wrong (Absolute Contraindications) * **Valvular Heart Disease:** If complicated by pulmonary hypertension, atrial fibrillation, or a history of subacute bacterial endocarditis, it is Category 4 due to the high risk of thromboembolism. * **Migraine with Focal Aura:** Estrogen increases the risk of ischemic stroke. Migraine with aura at any age is a Category 4 contraindication. * **History of Breast Cancer:** Breast cancer is a hormone-dependent tumor. Any current or past history of breast cancer is Category 4 because exogenous estrogen can stimulate tumor growth or recurrence. ### High-Yield Clinical Pearls for NEET-PG * **Mnemonic for Absolute Contraindications (C-H-E-C-K):** **C**ancer (Breast/Genital), **H**eart disease/Hypertension ($\geq$160/100), **E**mbolism (DVT/PE), **C**oagulation disorders, **K**liver (Liver) disease/Cirrhosis. * **Undiagnosed Vaginal Bleeding:** This is an absolute contraindication until malignancy is ruled out. * **Postpartum:** COCPs are contraindicated for the first 3 weeks postpartum due to high VTE risk, and for 6 months if breastfeeding (Category 4).

Question 1

Peritoneum is opened in all of the following sterilization procedures except?

Accepted Answer

Vasectomy

Answer

Mini lap

Answer

Laparoscopy

Answer

Transvaginal tubectomy

Question 2

What is the recommended lifespan of a Copper T 380A intrauterine device?

Accepted Answer

10 years

Answer

4 years

Answer

5 years

Answer

3 years

Question 3

A 27-year-old P2L2 presents to the OPD for contraceptive advice. She delivered a male child 3 weeks ago and is presently lactating. She has no contraindications to hormone use. What contraceptive method can be given?

Accepted Answer

Minipill (Progestin-only pill)

Answer

DMPA (Depot medroxyprogesterone acetate)

Answer

Levonorgestrel implants

Answer

Combined oral contraceptive pills (OCPs)

Question 4

Which of the following statements is TRUE regarding spermicides found in vaginal foams, creams, and suppositories?

Accepted Answer

The active agent in these spermicides is nonoxynol-9.

Answer

The active agent in these spermicides is levonorgestrel.

Answer

Effectiveness is higher in younger users.

Answer

Effectiveness is higher than that of the diaphragm.

Question 5

What is the primary mechanism of action of oral contraceptives containing ethinyl estradiol and a progestin?

Accepted Answer

Inhibition of ovulation

Answer

Inhibition of implantation

Answer

Thickening of cervical mucus

Answer

None of the above

Question 6

What is the most common side effect of an Intrauterine Contraceptive Device (IUCD) that necessitates its removal?

Accepted Answer

Pain

Answer

Bleeding

Answer

Pelvic infection

Answer

Ectopic pregnancy

Question 7

Centchroman is:

Accepted Answer

A nonsteroidal oral contraceptive

Answer

A new drug for fibroids

Answer

A new drug for endometriosis

Answer

An injectable contraceptive

Question 8

Which of the following conditions can be indicated for Medical Termination of Pregnancy (MTP)?

Accepted Answer

If maternal health is in danger

Answer

Pregnancy caused by rape

Answer

Husband is willing but mother is not agreeing

Answer

Pregnancy after contraceptive failure

Question 9

Which of the following is NOT an absolute contraindication for oral contraceptive pills?

Accepted Answer

Smoking

Answer

Valvular heart disease

Answer

Migraine with focal aura

Answer

History of breast cancer

Question 10

With DMPA, the next injection may be taken latest by:

Accepted Answer

17 weeks

Answer

12 weeks

Answer

13 weeks

Answer

15 weeks

Contraception and Family Planning — MCQs

Contraception and Family Planning — MCQs

On this page

Practice by Chapter

Want unlimited practice?